• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板衍生生长因子-CC 异构体与组织型纤溶酶原激活物治疗的缺血性脑卒中患者的出血性转化相关。

Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.

机构信息

Clinical Neurosciences Research Laboratory, Neurovascular Area, Department of Neurology, Hospital Clínico Universitario, IDIS, University of Santiago de Compostela, Santiago de Compostela, Spain.

出版信息

Atherosclerosis. 2013 Jan;226(1):165-71. doi: 10.1016/j.atherosclerosis.2012.10.072. Epub 2012 Nov 17.

DOI:10.1016/j.atherosclerosis.2012.10.072
PMID:23218119
Abstract

OBJECTIVE

Platelet derived growth factor-CC (PDGF-CC) isoform is activated by tissue plasminogen activator (tPA) regulating blood brain barrier permeability after ischemia. We aimed to study the association of PDGF isoforms serum levels with hemorrhagic transformation (HT) and edema after thrombolytic treatment in ischemic stroke.

METHODS

We studied 129 patients with ischemic stroke treated with tPA within the first 4.5 h (h) from stroke onset. CT was performed on admission and at 24-36 h. On the 2nd CT, HT was classified according to ECASS II criteria, and severe brain edema was diagnosed if extensive swelling causing any shifting of the structures of the midline was detected. PDGF-AA, PDGF-AB, PDGF-BB and PDGF-CC serum levels were analyzed by ELISA on admission (before tPA bolus), at 24 and 72 h.

RESULTS

Patients who developed HT showed only higher levels of PDGF-CC isoform on admission and at 24 h (all p < 0.0001). In the multivariate analysis, PDGF-CC levels on admission (OR, 1.02; CI 95%, 1.00-1.04) and at 24 h (OR, 1.05; CI 95%, 1.02-1.08) were independently associated with HT after adjustment by confounding factors. On the other hand, patients with severe edema showed also higher levels of PDGF-CC on admission and at 24 h (p < 0.0001), but this statistical association was lost in the logistic regression analysis. PDGF-CC levels ≥ 175 ng/mL at 24 h predict the development of PH with a sensitivity of 90% and specificity of 88% (area under the curve 0.936; p < 0.0001).

CONCLUSION

Increased PDGF-CC levels after tPA treatment is associated with HT.

摘要

目的

血小板衍生生长因子-CC(PDGF-CC)异构体通过组织型纤溶酶原激活物(tPA)激活,调节缺血后血脑屏障通透性。我们旨在研究 PDGF 异构体血清水平与缺血性卒中溶栓治疗后出血性转化(HT)和水肿的关系。

方法

我们研究了 129 例在卒中发病后 4.5 小时内接受 tPA 治疗的缺血性卒中患者。入院时和 24-36 小时进行 CT 检查。在第 2 次 CT 上,根据 ECASS II 标准对 HT 进行分类,如果广泛肿胀导致中线结构任何移位,则诊断为严重脑水肿。入院时(tPA 推注前)、24 小时和 72 小时通过 ELISA 分析 PDGF-AA、PDGF-AB、PDGF-BB 和 PDGF-CC 血清水平。

结果

发生 HT 的患者在入院时和 24 小时时仅表现出更高的 PDGF-CC 异构体水平(均 p<0.0001)。在多变量分析中,入院时(OR,1.02;95%CI,1.00-1.04)和 24 小时(OR,1.05;95%CI,1.02-1.08)时的 PDGF-CC 水平与调整混杂因素后的 HT 独立相关。另一方面,严重水肿的患者在入院时和 24 小时时也表现出更高的 PDGF-CC 水平(p<0.0001),但在逻辑回归分析中这种统计学关联消失了。24 小时时 PDGF-CC 水平≥175ng/mL 预测 PH 的发生,具有 90%的敏感性和 88%的特异性(曲线下面积 0.936;p<0.0001)。

结论

tPA 治疗后 PDGF-CC 水平升高与 HT 相关。

相似文献

1
Platelet derived growth factor-CC isoform is associated with hemorrhagic transformation in ischemic stroke patients treated with tissue plasminogen activator.血小板衍生生长因子-CC 异构体与组织型纤溶酶原激活物治疗的缺血性脑卒中患者的出血性转化相关。
Atherosclerosis. 2013 Jan;226(1):165-71. doi: 10.1016/j.atherosclerosis.2012.10.072. Epub 2012 Nov 17.
2
Microglial-mediated PDGF-CC activation increases cerebrovascular permeability during ischemic stroke.小胶质细胞介导的血小板衍生生长因子-CC 激活增加缺血性脑卒中期间的脑血管通透性。
Acta Neuropathol. 2017 Oct;134(4):585-604. doi: 10.1007/s00401-017-1749-z. Epub 2017 Jul 19.
3
Increased body iron stores are associated with poor outcome after thrombolytic treatment in acute stroke.急性卒中溶栓治疗后,体内铁储备增加与预后不良相关。
Stroke. 2007 Jan;38(1):90-5. doi: 10.1161/01.STR.0000251798.25803.e0. Epub 2006 Nov 30.
4
A higher body temperature is associated with haemorrhagic transformation in patients with acute stroke untreated with recombinant tissue-type plasminogen activator (rtPA).体温升高与未使用重组组织型纤溶酶原激活剂(rtPA)治疗的急性脑卒中患者的出血性转化有关。
Clin Sci (Lond). 2012 Feb;122(3):113-9. doi: 10.1042/CS20110143.
5
The THRIVE score predicts symptomatic intracerebral hemorrhage after intravenous tPA administration in SITS-MOST.在SITS-MOST研究中,THRIVE评分可预测静脉注射组织型纤溶酶原激活剂(tPA)后症状性脑出血的发生。
Int J Stroke. 2014 Aug;9(6):705-10. doi: 10.1111/ijs.12335. Epub 2014 Jul 15.
6
Activation of PDGF-CC by tissue plasminogen activator impairs blood-brain barrier integrity during ischemic stroke.组织型纤溶酶原激活剂激活血小板衍生生长因子CC会损害缺血性中风期间的血脑屏障完整性。
Nat Med. 2008 Jul;14(7):731-7. doi: 10.1038/nm1787. Epub 2008 Jun 22.
7
Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.携带基质金属蛋白酶-9基因启动子区域常见多态性(C-1562T)的中风患者接受组织纤溶酶原激活剂治疗的安全性概况。
Stroke. 2003 Dec;34(12):2851-5. doi: 10.1161/01.STR.0000098648.54429.1C. Epub 2003 Nov 6.
8
Plasma cellular-fibronectin concentration predicts hemorrhagic transformation after thrombolytic therapy in acute ischemic stroke.血浆细胞纤维连接蛋白浓度可预测急性缺血性卒中溶栓治疗后的出血性转化。
Stroke. 2004 Jul;35(7):1671-6. doi: 10.1161/01.STR.0000131656.47979.39. Epub 2004 May 27.
9
Body temperature and response to thrombolytic therapy in acute ischaemic stroke.急性缺血性卒中患者的体温与溶栓治疗反应
Eur J Neurol. 2008 Dec;15(12):1384-9. doi: 10.1111/j.1468-1331.2008.02321.x.
10
A large screening of angiogenesis biomarkers and their association with neurological outcome after ischemic stroke.大样本血管生成生物标志物筛选及其与缺血性脑卒中后神经功能结局的相关性。
Atherosclerosis. 2011 May;216(1):205-11. doi: 10.1016/j.atherosclerosis.2011.01.030. Epub 2011 Jan 26.

引用本文的文献

1
O2L-001, an innovative thrombolytic to evacuate intracerebral haematoma.O2L-001,一种创新的溶栓药物,可用于清除颅内血肿。
Brain. 2023 Nov 2;146(11):4690-4701. doi: 10.1093/brain/awad237.
2
Thrombolytic tPA-induced hemorrhagic transformation of ischemic stroke is mediated by PKCβ phosphorylation of occludin.血栓溶解 tPA 诱导的缺血性中风出血性转化是由 occludin 的蛋白激酶 Cβ磷酸化介导的。
Blood. 2022 Jul 28;140(4):388-400. doi: 10.1182/blood.2021014958.
3
Hemorrhagic Transformation in Acute Ischemic Stroke: A Quantitative Systematic Review.
急性缺血性卒中的出血性转化:一项定量系统评价
J Clin Med. 2022 Feb 22;11(5):1162. doi: 10.3390/jcm11051162.
4
Hemorrhagic Transformation After Ischemic Stroke: Mechanisms and Management.缺血性卒中后的出血性转化:机制与管理
Front Neurol. 2021 Nov 30;12:703258. doi: 10.3389/fneur.2021.703258. eCollection 2021.
5
Predicting hemorrhagic transformation after large vessel occlusion stroke in the era of mechanical thrombectomy.预测机械取栓时代大血管闭塞性卒中后的出血性转化。
PLoS One. 2021 Aug 16;16(8):e0256170. doi: 10.1371/journal.pone.0256170. eCollection 2021.
6
Plasma Biomarkers as Potential Predictors of Functional Dependence in Daily Life Activities after Ischemic Stroke: A Single Center Study.血浆生物标志物作为缺血性中风后日常生活活动功能依赖的潜在预测指标:一项单中心研究
Ann Indian Acad Neurol. 2020 Jul-Aug;23(4):496-503. doi: 10.4103/aian.AIAN_74_19. Epub 2019 May 14.
7
The presence of leukoaraiosis enhances the association between sTWEAK and hemorrhagic transformation.脑白质疏松症的存在增强了 sTWEAK 与出血转化之间的关联。
Ann Clin Transl Neurol. 2020 Nov;7(11):2103-2114. doi: 10.1002/acn3.51171. Epub 2020 Oct 6.
8
PDGF/PDGFR axis in the neural systems.血小板衍生生长因子/血小板衍生生长因子受体轴在神经系统中的作用。
Mol Aspects Med. 2018 Aug;62:63-74. doi: 10.1016/j.mam.2018.01.006. Epub 2018 Feb 6.
9
Discovery of High-Affinity PDGF-VEGFR Interactions: Redefining RTK Dynamics.高亲和力 PDGF-VEGFR 相互作用的发现:重新定义 RTK 动力学。
Sci Rep. 2017 Nov 27;7(1):16439. doi: 10.1038/s41598-017-16610-z.
10
Randomized assessment of imatinib in patients with acute ischaemic stroke treated with intravenous thrombolysis.对接受静脉溶栓治疗的急性缺血性脑卒中患者使用伊马替尼的随机评估。
J Intern Med. 2017 Mar;281(3):273-283. doi: 10.1111/joim.12576. Epub 2016 Nov 14.